Neoadjuvant Nivolumab Plus Ipilimumab Versus Adjuvant Nivolumab in Macroscopic, Resectable Stage III Melanoma: the Phase 3 NADINA Trial.

Minke W. Lucas,Richard A. Scolyer, Bart A. van de Wiel,Alexander M. Menzies, Marta I. Lopez-Yurda, Alexander Christopher Jonathan van Akkooi, Winan J. van Houdt, Robyn P. M. Saw, Alex Torres Acosta, Serigne N. Lo, Geke Hospers, Matteo S. Carlino, Jan Willem de Groot,Ellen Kapiteijn, Karijn Suijkerbuijk,Piotr Rutkowski,Shahneen Sandhu, Astrid Aplonia Maria van der Veldt, Georgina V. Long

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用 0|浏览0

暂无评分

关键词

283-232,227-12145,298-145-222-184-1022-9126,281-318-9493,298-7687-2370-7650-5110,298-145-222-184-1022-9124,261-374,14,47,3581,166,242,3616

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要